Renalytix PLC
LSE:RENX
Balance Sheet
Balance Sheet Decomposition
Renalytix PLC
Current Assets | 28.3m |
Cash & Short-Term Investments | 26.3m |
Receivables | 776k |
Other Current Assets | 1.3m |
Non-Current Assets | 13.8m |
PP&E | 1.2m |
Intangibles | 12.5m |
Other Non-Current Assets | 51k |
Current Liabilities | 16.1m |
Accounts Payable | 2.9m |
Accrued Liabilities | 8.6m |
Other Current Liabilities | 4.6m |
Non-Current Liabilities | 7.5m |
Long-Term Debt | 7.5m |
Balance Sheet
Renalytix PLC
Jun-2018 | Jun-2019 | Jun-2020 | Jun-2021 | Jun-2022 | Jun-2023 | ||
---|---|---|---|---|---|---|---|
Assets | |||||||
Cash & Cash Equivalents |
0
|
9
|
13
|
65
|
41
|
25
|
|
Cash |
0
|
0
|
13
|
65
|
41
|
25
|
|
Cash Equivalents |
0
|
9
|
0
|
0
|
0
|
0
|
|
Short-Term Investments |
0
|
0
|
1
|
9
|
3
|
2
|
|
Total Receivables |
0
|
0
|
0
|
1
|
1
|
1
|
|
Accounts Receivables |
0
|
0
|
0
|
1
|
1
|
1
|
|
Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
|
Inventory |
0
|
0
|
0
|
0
|
1
|
1
|
|
Other Current Assets |
0
|
0
|
4
|
1
|
1
|
1
|
|
Total Current Assets |
0
|
9
|
19
|
76
|
47
|
28
|
|
PP&E Net |
0
|
0
|
1
|
1
|
2
|
1
|
|
PP&E Gross |
0
|
0
|
1
|
1
|
2
|
1
|
|
Accumulated Depreciation |
0
|
0
|
0
|
0
|
1
|
1
|
|
Intangible Assets |
0
|
18
|
17
|
18
|
14
|
13
|
|
Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
|
Long-Term Investments |
0
|
0
|
2
|
0
|
0
|
0
|
|
Other Long-Term Assets |
0
|
1
|
2
|
7
|
0
|
0
|
|
Total Assets |
0
N/A
|
29
+50 972%
|
41
+43%
|
103
+148%
|
63
-38%
|
42
-33%
|
|
Liabilities | |||||||
Accounts Payable |
0
|
0
|
2
|
2
|
2
|
3
|
|
Accrued Liabilities |
0
|
0
|
1
|
5
|
5
|
9
|
|
Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
|
Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
5
|
5
|
|
Other Current Liabilities |
0
|
0
|
2
|
1
|
0
|
0
|
|
Total Current Liabilities |
0
|
1
|
5
|
7
|
12
|
16
|
|
Long-Term Debt |
0
|
0
|
0
|
0
|
8
|
8
|
|
Total Liabilities |
0
N/A
|
1
+1 044%
|
5
+607%
|
7
+40%
|
20
+169%
|
24
+18%
|
|
Equity | |||||||
Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
|
Retained Earnings |
0
|
6
|
35
|
4
|
53
|
99
|
|
Additional Paid In Capital |
0
|
34
|
0
|
76
|
85
|
105
|
|
Other Equity |
0
|
0
|
1
|
15
|
10
|
12
|
|
Total Equity |
0
N/A
|
28
N/A
|
36
+28%
|
95
+164%
|
43
-55%
|
18
-57%
|
|
Total Liabilities & Equity |
0
N/A
|
29
+50 972%
|
41
+43%
|
103
+148%
|
63
-38%
|
42
-33%
|
|
Shares Outstanding | |||||||
Common Shares Outstanding |
54
|
54
|
59
|
71
|
73
|
94
|